证券代码：001328 证券简称：登康口腔 公告编号：2023-038 2.本次无偿划转将导致重庆渝富控股集团有限公司（以下简称"渝富控股"）间 接收购重庆轻纺控股（集团）公司（以下简称"轻纺控股"）持有的重庆登康口腔护 理用品股份有限公司（以下简称"公司"）59.83%的股份。同时，渝富控股一致行动 人重庆百货大楼股份有限公司（以下简称"重庆百货"）持有公司1.74%的股份。本次 无偿划转事宜完成后，渝富控股及其一致行动人合计控制的公司股份比例由1.74%提升 至61.57%，轻纺控股仍为公司控股股东，重庆市国资委仍为公司实际控制人。 一、本次权益变动基本情况概述 根据重庆市国资委下发的《重庆市国有资产监督管理委员会关于无偿划转重庆轻 纺控股（集团）公司80%股权的通知》（渝国资﹝2023﹞379号），重庆市国资委将持 有的轻纺控股80%的股权无偿划转给渝富控股。公司已于2023年10月10日发布《关于股 东权益变动的提示性公告》（公告编号：2023-037号）。 重庆登康口腔护理用品股份有限公司 关于收购报告书摘要及股东权益变动的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有 ...

证券代码：001328 证券简称：登康口腔 公告编号：2023-037 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 董事会 2023年10月8日，重庆登康口腔护理用品股份有限公司（以下简称"公司"）收到 股东重庆轻纺控股（集团）公司（以下简称"轻纺控股"）转发的《重庆市国有资产 监督管理委员会关于无偿划转重庆轻纺控股（集团）公司80%股权的通知》（渝国资 ﹝2023﹞379号），重庆市国资委将持有的轻纺控股80%的股权无偿划转给重庆渝富控 股集团有限公司（以下简称"渝富控股"）。 上述事项将导致渝富控股间接收购轻纺控股持有的公司59.83%的股份。同时，渝 富控股一致行动人重庆百货大楼股份有限公司（以下简称"重庆百货"）持有公司 1.74%的股份。本次无偿划转事宜完成后，渝富控股及其一致行动人合计控制的公司股 份比例由1.74%提升至61.57%，轻纺控股仍为公司控股股东，重庆市国资委仍为公司实 际控制人。本次划转不会对公司日常生产经营活动构成重大影响。 为保证及时、公平地披露信息，维护广大投资者利益，现予以公告。后续，公司 将严格按照分阶段信息披露要求， ...

证券代码：001328 证券简称：登康口腔 公告编号：2023-036 重庆登康口腔护理用品股份有限公司 关于首次公开发行网下配售限售股上市流通的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1. 本次解除限售的股份为重庆登康口腔护理用品股份有限公司（以下简称"登康 口腔"或"公司"或"发行人"）首次公开发行网下配售限售股； 经中国证券监督管理委员会《关于同意重庆登康口腔护理用品股份有限公司首次 公开发行股票注册的批复》（证监许可〔2023〕585号）核准，并经深圳证券交易所 《关于重庆登康口腔护理用品股份有限公司人民币普通股股票上市的通知》（深证上 〔2023〕278号）同意，公司首次公开发行人民币普通股股票（A股）43,043,500股， 并于2023年4月10日在深圳证券交易所主板上市，股票简称"登康口腔"，股票代码 "001328"。 公司首次公开发行前总股本为129,130,300股，首次公开发行股票后，总股本为 172,173,800股，其中：有流通限制或锁定安排的股票数量为129,994,353股，占发行 后总股本比例为 ...

中信建投证券股份有限公司 关于重庆登康口腔护理用品股份有限公司 本次申请上市流通的限售股属于公司首次公开发行网下配售限售股，股份数 量为 864,053 股，占发行后总股本的 0.50%，限售期为自公司股票上市之日起 6 个月，该部分限售股将于 2023 年 10 月 10 日（星期二）上市流通。 首次公开发行网下配售限售股上市流通的核查意见 中信建投证券股份有限公司（以下简称"保荐人"）作为重庆登康口腔护理 用品股份有限公司（以下简称"登康口腔""公司"）首次公开发行股票并在主板 上市的保荐人，根据《证券发行上市保荐业务管理办法》《深圳证券交易所股票 上市规则（2023 年修订）》《深圳证券交易所上市公司自律监管指引第 1 号—— 主板上市公司规范运作》《深圳证券交易所上市公司自律监管指引第 13 号——保 荐业务》等有关规定，对登康口腔首次公开发行网下配售限售股上市流通的事项 进行了审慎核查，核查情况及核查意见如下： 1 一、首次公开发行股票和网下配售股份概况 自首次公开发行网下配售限售股形成至本核查意见出具日，公司未发生因股 份增发、回购注销、派发股份股利或资本公积金转增股本等导致公司股本总额变 动的情 ...

证券代码：001328 证券简称：登康口腔 公告编号：2023-035 重庆登康口腔护理用品股份有限公司 2023年第三次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1. 本次股东大会无否决议案或修改议案的情况； 2. 本次股东大会上没有新提议案提交表决； 3. 本次股东大会不涉及变更前次股东大会决议的情况； 4. 本次股东大会第（一）项议案需对中小股东表决单独计票； 本次股东大会采取现场方式召开，采用现场投票和网络投票相结合的方式进行表 决。 5. 本次股东大会采取现场方式召开，采用现场投票和网络投票相结合的方式进行 表决。 一、会议召开情况 （一）会议召开时间 1. 现场会议召开时间：2023年9月20日（星期三）14:30。 2. 网络投票时间： （1）深圳证券交易所交易系统进行网络投票的具体时间为2023年9月20日 9:15— 9:25，9:30—11:30和13:00—15:00； （2）深圳证券交易所互联网投票系统投票的具体时间为2023年9月20日9:15- 15:00。 （二）会议召开和表决方式 （三）召 ...

上海锦天城（广州）律师事务所 关于重庆登康口腔护理用品股份有限公司 2023 年第三次临时股东大会的 法律意见书 地址：广州市天河区珠江西路 5 号广州国际金融中心第 60 层 电话：020-8928 1168 传真：020-8928 5188 邮编：510623 上海市锦天城律师事务所 法律意见书 上海锦天城（广州）律师事务所 关于重庆登康口腔护理用品股份有限公司 2023 年第三次临时股东大会的 致：重庆登康口腔护理用品股份有限公司 上海锦天城（广州）律师事务所（以下简称"本所"）接受重庆登康口腔 护理用品股份有限公司（以下简称"公司"）委托，就公司召开 2023 年第三次 临时股东大会（以下简称"本次股东大会"或"本次会议"）的有关事宜，根 据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和 国证券法》（以下简称"《证券法》"）和《上市公司股东大会规则（2022 年 修订）》（以下简称"《股东大会规则》"）、《深圳证券交易所上市公司股 东大会网络投票实施细则（2020 年修订）》等法律、法规、规章和其他规范性 文件以及《重庆登康口腔护理用品股份有限公司章程》（以下简称"《公司章 程》" ...

Financial Performance - The company's operating revenue for the first half of 2023 was CNY 666,821,265.52, representing a 9.19% increase compared to CNY 610,693,280.44 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was CNY 65,969,145.08, up 13.48% from CNY 58,131,070.60 year-on-year[22]. - The net cash flow from operating activities increased by 69.29% to CNY 32,323,151.72, compared to CNY 19,059,551.05 in the previous year[22]. - Total assets at the end of the reporting period reached CNY 1,778,333,744.51, a 74.70% increase from CNY 1,017,942,306.12 at the end of the previous year[22]. - The net assets attributable to shareholders of the listed company increased by 145.40% to CNY 1,330,759,464.39, compared to CNY 542,280,126.94 at the end of the previous year[22]. - Basic earnings per share decreased by 2.73% to CNY 0.4379, down from CNY 0.4502 in the same period last year[22]. - The weighted average return on net assets was 6.68%, down 4.48% from 11.16% in the previous year[22]. - The company reported a total non-operating income of 14,023,013.29, which includes government subsidies and fair value changes from financial assets[26]. - The company reported a government subsidy income of 12,550,665.79, which is significant for its operational support[26]. - The company reported a net investment income of CNY 1,306,218.65, accounting for 1.74% of total profit[81]. Product Development and Innovation - The company focuses on oral care products, including toothpaste, toothbrushes, mouthwash, and electric oral care devices, forming a comprehensive product matrix[30]. - The company has developed a series of innovative toothpaste products, including a patented desensitizing toothpaste that utilizes bioactive glass-ceramic materials[30]. - The company aims to provide a wide range of oral health solutions, targeting both adults and children with specialized products for sensitive teeth and oral hygiene[30]. - The company emphasizes a strategic focus on deepening its core business in oral care, aiming to become a world-leading oral health expert[30]. - The company has introduced a new pump-style packaging for toothpaste, appealing to younger consumers with its innovative design[30]. - The company has established partnerships with academic institutions for product development, enhancing its research capabilities[30]. - The company has developed a new series of sensitive toothpaste and toothbrushes, focusing on reducing external stimuli and enhancing oral care for children aged 0-12[31]. - The new children's toothpaste series includes a fun dog paw-shaped bottle and scientifically formulated ingredients to combat high cavity rates, which stand at 71.9% for children's primary teeth[31]. - The electric toothbrush series features a sonic motor with a vibration frequency of approximately 31,000 to 48,000 times per minute, designed to effectively reduce plaque and provide gentle gum care[31]. - The company is expanding its product line to include various children's oral care products, such as fun-flavored toothpaste and engaging brushing experiences to encourage good habits[31]. - The new product development strategy emphasizes the use of high-quality materials and innovative designs to meet the specific needs of different age groups[31]. - The company aims to enhance market presence through collaborations with popular children's IPs, such as Paw Patrol and Transformers, to attract young consumers[31]. - The introduction of new technologies in product formulations, such as micro-fluoride and freeze-dried probiotics, aims to improve the effectiveness of cavity prevention[31]. - The company is committed to providing a comprehensive oral care solution for children, including toothbrushes and toothpaste tailored to their developmental stages[31]. - Future outlook includes continued innovation in oral care products and potential market expansion to address the growing demand for children's dental health solutions[31]. Market Trends and Consumer Behavior - In the first half of 2023, the domestic offline toothpaste market sales reached CNY 11.18 billion, a decline of 6.5% year-on-year, while the toothbrush market sales were CNY 3.85 billion, showing a year-on-year growth of 1.1%[34]. - The market share of the top ten toothpaste manufacturers in China accounted for 81.0% of the offline retail market in the first half of 2023, with the top four manufacturers, including Chongqing Dengkang, holding a combined market share of 60.6%, up from 59.9% in the same period last year[39]. - The oral health awareness among consumers is increasing, leading to a rise in per capita spending on oral care products, which is expected to drive growth in the oral care industry[35]. - The online market for oral care products continues to grow, while the offline retail market is still in a recovery phase, indicating a shift in consumer purchasing behavior[34]. - The rise of national brands is contributing to the growth of the oral care market, with local brands gaining market share through product upgrades and improved sales strategies[36]. - The company is responding to the trend of increasing consumer demand for diverse and personalized oral care products, enhancing its product offerings accordingly[35]. Research and Development - The company invested 19.84 million yuan in R&D, a 14.56% increase compared to the previous year, outpacing revenue growth[50]. - The company has over 200 domestic authorized patents, including more than 20 invention patents, and 580 registered trademarks as of the end of the reporting period[51]. - The company continues to focus on the oral health sector, enhancing its innovation capabilities and establishing a research center for sensitive teeth[50]. - The company has signed strategic cooperation agreements with Shanghai Jiao Tong University and the National University of Singapore to deepen industry-academia-research collaboration[51]. - The company has conducted 22 research surveys to improve operational management and supply chain capabilities, demonstrating a commitment to data-driven decision-making[55]. Marketing and Brand Strategy - The company is actively expanding its marketing network, achieving growth across various channels, including KA, distribution, and new retail[48]. - The company emphasizes digital marketing transformation, enhancing brand influence and user engagement through digital media platforms[46]. - The company has adopted a digital marketing strategy, winning multiple awards for innovative brand campaigns from 2019 to 2023, enhancing its brand recognition among younger consumers[58]. - The company has established a robust channel management system, integrating online and offline sales to adapt to changing consumer shopping habits[60]. - The company has implemented a multi-brand strategy, including brands like "Dengkang," "Cold Acid Spirit," and "Beilele," to cater to diverse consumer needs across different age groups[57]. - The company plans to enhance brand construction and digital marketing transformation to improve brand influence[101]. - The company emphasizes the importance of brand image, investing significant resources annually to maintain and enhance it[102]. Financial Management and Governance - The company successfully completed its IPO on April 10, 2023, becoming the first company to list under the new registration system on the Shenzhen Stock Exchange, enhancing brand awareness and capital strength[53]. - The company raised a total of RMB 89,013.96 million through the issuance of 43.04 million shares at RMB 20.68 per share, with a net amount of RMB 82,581.45 million after deducting underwriting fees and related expenses of RMB 6,432.51 million[92]. - As of June 30, 2023, the total unused raised funds amounted to RMB 67,506.12 million, which includes unpaid issuance expenses of RMB 130.09 million, all of which are stored in a dedicated account[93]. - The company has committed to invest RMB 66,000 million in various projects, with RMB 15,205.42 million already utilized, representing 23.05% of the total commitment[95]. - The company has not sold any significant assets during the reporting period[98]. - The company has not disclosed any important information regarding major controlling or affiliated companies during the reporting period[99]. - The company has not reported any major changes in the feasibility of its investment projects during the reporting period[96]. - The company has not reported any significant impact on its daily operations due to the proposed share transfer[138]. - The company has not reported any major environmental issues or administrative penalties during the reporting period[115]. - The financial statements were approved by the board of directors on August 25, 2023, indicating a commitment to transparency and governance[195]. Shareholder Engagement - The company held two temporary shareholder meetings with 100% investor participation on February 18, 2023, and March 24, 2023, and an annual meeting with 75.01% participation on June 15, 2023[109]. - The company plans not to distribute cash dividends or issue bonus shares for the half-year period[111]. - The company provided over 120,000 yuan in public welfare sponsorships during the reporting period, focusing on oral health education and community support[115]. - The actual occurrence of related party transactions in the first half of 2023 amounted to 4.712 million yuan, which is 20.85% of the approved transaction amount of 18 million yuan[124]. - There were no significant lawsuits or arbitration matters during the reporting period[123]. - The company did not experience any non-operating fund occupation by controlling shareholders or related parties[119]. Operational Efficiency - The company has implemented a lean production system and advanced technology to enhance supply chain management, ensuring timely and safe raw material supply[70]. - The management team has an average service tenure of over 20 years, bringing extensive experience and insight into the oral care industry[73]. - The company has implemented an incentive system to encourage value creation and enhance employee engagement, fostering a culture of innovation[54]. - The company is focusing on technological innovation and product development to meet diverse market demands and enhance core competitiveness[106]. - The company recognizes the risk of talent loss and is implementing strategies to attract and retain core technical and management personnel[107]. - The company is actively addressing the challenges posed by e-commerce and new retail formats to ensure stable sales performance[105]. Future Outlook - The company has set a target for future growth, aiming for a revenue increase of 10% year-over-year for the next fiscal year[181]. - The company plans to invest in new product development, focusing on innovative dental care solutions to expand its market presence[181]. - The company has initiated a market expansion strategy targeting international markets, particularly in Southeast Asia, to increase its customer base[181]. - The company is exploring potential mergers and acquisitions to enhance its product offerings and market share[181]. - The management provided a positive outlook for the second half of 2023, expecting continued revenue growth driven by new product launches[185].

重庆登康口腔护理用品股份有限公司 董事会授权管理制度 第一章 总则 第一条 为进一步完善重庆登康口腔护理用品股份有限公司（以下简称"公 司"）的法人治理结构，规范董事会对经理层的授权事项，加强内部控制和风险 管理，提高经营决策效率，提升公司的规范运作水平，根据《中华人民共和国公 司法》《中华人民共和国证券法》《重庆登康口腔护理用品股份有限公司章程》 （以下简称"《公司章程》"）的规定，制定本制度。 第二条 本制度所称"授权"，指董事会在一定条件和范围内，将法律、行 政法规以及《公司章程》所赋予的部分职权委托经理层或总经理代为行使的行为。 第三条 本制度所称"经理层"，指负责公司经营管理工作的人员，包括总 经理、副总经理、财务负责人、董事会秘书等高级管理人员。 第四条 董事会的授权应当遵循以下原则： （一）依法审慎原则：授权应当严格依照法律、行政法规和《公司章程》等 规定，优先考虑风险防范目标的要求，合理确定授权事项及权限划分标准。 （二）适时调整原则：授权事项在授权有效期限内保持相对稳定，并根据内 外部因素的变化情况和经营管理工作的需要适时调整。 （三）权责统一原则：权力与责任同时发生、不可分割，行使权力的同 ...

证券代码：001328 证券简称：登康口腔 公告编号：2023-033 重庆登康口腔护理用品股份有限公司 关于改选第七届董事会薪酬与考核委员会委员的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 重庆登康口腔护理用品股份有限公司（以下简称"公司"）于2023年8月25日召开的 第七届董事会第十一次会议审议通过了《关于改选第七届董事会薪酬与考核委员会委员 的议案》。现将具体事项公告如下： 公司薪酬与考核委员会委员赵丰硕先生因工作需要，请求辞去公司第七届董事会薪 酬与考核委员会委员职务。经公司董事长邓嵘先生提名，董事会同意选举公司董事孙德 寿先生（简历详见附件）为公司第七届董事会薪酬与考核委员会委员，任期自本次董事 会审议通过之日起，至第七届董事会届满时止。 本次调整后，赵丰硕先生仍为公司董事、总经理、战略委员会委员。公司第七届董 事会薪酬与考核委员会由廖成林先生（主任委员）、靳景玉先生、孙德寿先生共同组 成。 特此公告 重庆登康口腔护理用品股份有限公司 董事会 2023年8月25日 附件： 孙德寿先生简历 孙德寿先生，1985年生，中国国籍，无境外永久居留 ...

证券代码：001328 证券简称：登康口腔 公告编号：2023-027 重庆登康口腔护理用品股份有限公司 第七届董事会第十一次会议决议公告 （二）本次会议于2023年8月25日上午10:00在公司办公楼三楼二会议室以现场结合 通讯表决的方式召开。 （三）本次会议应到董事8名，实际出席并表决的董事8名。其中：董事邓嵘、赵 丰硕、王青杰、许杰以及独立董事廖成林、靳景玉参加现场会议表决；董事孙德寿、 独立董事王海兵以通讯表决方式出席会议。 （四）公司董事长邓嵘先生主持会议，公司监事及全体高级管理人员列席会议。 （五）本次会议的通知、召集和召开符合《中华人民共和国公司法》等法律、行 政法规、部门规章、规范性文件及《重庆登康口腔护理用品股份有限公司章程》的有 关规定。 二、董事会会议审议情况 （一）审议通过《关于<2023年半年度报告>及其摘要的议案》 表决情况：同意8票，反对0票，弃权0票 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 （一）重庆登康口腔护理用品股份有限公司（以下简称"公司"）第七届董事会 第十一次会议（以下简称"本次会议"） ...